Samtidige faste doser af aminosalicylater, kortikosteroider, og/ eller immunmodulerende- midler var tilladt, og 79% af
Concomitant stable doses of aminosalicylates, corticosteroids, and/ or immunomodulatory agents were permitted and 79% of patients continued to receive at least one of these medications. t